GLOBUS MEDICAL, INC. Contract Liability (Deferred Revenue)
GLOBUS MEDICAL, INC. (GMED) had Contract Liability (Deferred Revenue) of $27.98 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Contract with Customer, Liability, Current $27.98M.
- 2026-03-31: Contract with Customer, Liability, Current $26.35M.
- 2025-12-31: Contract with Customer, Liability, Current $27.66M.
- 2024-12-31: Contract with Customer, Liability, Current $22.14M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $27.98M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $26.35M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $27.66M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $22.14M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |